Cardiovascular Pre-participation Screening in Children and Adolescents

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5-17
SponsorUniversity of Sao Paulo

About this trial

Sports participation is strongly encouraged in children and adolescents, but intense training at early ages may reveal hidden heart conditions that increase the risk of sudden cardiac death. Pre-participation evaluation aims to identify these conditions before sports practice.

This observational study will evaluate children and adolescents enrolled in the São Paulo Olympic Program (Programa São Paulo Olímpico). All participants will undergo a structured medical interview, a standardized physical examination and a resting 12-lead electrocardiogram (ECG). Participants with borderline ECG findings, warning symptoms, abnormal physical examination findings or a suggestive personal or family history will also undergo a 3-minute step test (Harvard step test) with continuous ECG recording during exercise and recovery, in order to detect exercise-induced arrhythmias.

The main goal is to estimate the prevalence of potentially pathological ECG findings in this population. The study will also describe warning signs in the medical history, abnormal physical examination findings, step test results, and the referrals and confirmed diagnoses during follow-up.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age under 18 years

Regular enrollment in organized sports in the São Paulo Olympic Program, with at least two training sessions per week

Informed consent signed by the legal guardian and assent signed by the participant

Availability to complete all study procedures (medical history, physical examination and resting electrocardiogram)

Disqualifiers

Inability to understand the study procedures

Refusal to participate by the legal guardian or the participant

Acute febrile illness in the 72 hours before data collection

Known structural heart disease under follow-up without medical clearance for sports practice

Trial population

Children and adolescents younger than 18 years regularly enrolled in organized sports in the São Paulo Olympic Program, with at least two training sessions per week, evaluated at the Heart Institute (InCor), São Paulo, Brazil.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Pre-participation clinical evaluation

    Other intervention

    Structured cardiovascular medical history and standardized physical examination.

  • Diagnostic Test: Resting 12-lead electrocardiogram

    Diagnostic test

    Resting 12-lead electrocardiogram (ECG) analyzed independently by two blinded sports cardiologists.

  • Diagnostic Test: Step test (Harvard step test)

    Diagnostic test

    3-minute continuous step test with electrocardiogram (ECG) recording during exercise and recovery, performed only in participants with borderline ECG findings, warning symptoms, abnormal physical examination or suggestive personal or family history.

Treatment groups

334 Participants
are divided into 1 treatment group
Group A: Young athletes3 interventions

Trial outcomes

Primary outcomes

1

Prevalence of potentially pathological findings on resting electrocardiogram

Proportion of participants whose resting 12-lead electrocardiogram (ECG) is classified as potentially pathological by two independent sports cardiologists blinded to clinical data, according to the study's operational classification

Time frame
At the pre-participation evaluation (day 1)

Secondary outcomes

1

Prevalence of warning signs and symptoms in the medical history

Proportion of participants reporting cardiovascular warning symptoms or a relevant personal or family history in the structured questionnaire.

Time frame
At the pre-participation evaluation (day 1)
2

Prevalence of abnormal physical examination findings

Proportion of participants with abnormal cardiovascular findings on standardized physical examination, including pathological murmurs, elevated blood pressure, abnormal pulses and Marfan phenotype.

Time frame
At the pre-participation evaluation (day 1)
3

Factors associated with potentially pathological findings

Association between potentially pathological findings and age, sex, sport and training load, expressed as odds ratios from multivariable logistic regression.

Time frame
At the pre-participation evaluation (day 1)
4

Prevalence of abnormal step test results

Proportion of participants undergoing the step test whose result is classified as borderline or abnormal (exercise-induced arrhythmias, significant ST-segment changes, dynamic T-wave inversion, prolonged corrected QT interval, high-grade atrioventricular block or symptoms during the test).

Time frame
Up to 30 days after the pre-participation evaluation

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: